论文部分内容阅读
按悉尼标准对139例各型慢性胃炎用CBS治疗4周作疗效分析,发现患者治疗后2周与4周症状缓解率比较有明显差异(P<0.05);治疗4周症状缓解率、胃镜改善率及病理组织学好转率三者呈阶梯状递减(90.09%,77.70%,60.43%),差异非常显著(P<0.01)。表明在CBS4周疗程中,随着治疗日的延长,症状缓解率将得以提高:而症状缓解与胃镜形态改善及组织学炎症好转并非一致。认为CBS治疗慢性胃炎疗程至少4周,疗效的判定不能单纯以症状是否缓解作为观察指标。
According to the Sydney standard of 139 cases of various types of chronic gastritis with CBS for 4 weeks for efficacy analysis found that patients 2 and 4 weeks after treatment symptoms were significantly different (P <0.05); 4 weeks treatment of symptoms, gastroscopic improvement rate (90.09%, 77.70%, 60.43%), the difference was significant (P <0.01). Showed that in the CBS 4 weeks course of treatment, with the extension of treatment days, the symptom relief rate will be improved: the symptom relief and gastroscope morphological improvement and histological inflammation is not the same. CBS treatment of chronic gastritis that at least 4 weeks, the efficacy of the judgment can not simply be the symptom? My remission as an indicator.